EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
Steering Committee
The Steering Committee will be meeting via conference call in December. A Belgian member has been appointed.
WG 1
WG 1 had its meeting on 27/10. The minutes went out this week and are available on SharePoint. At the moment, GML is checking the action items with Rahul. Once confirmation is received from Rahul, we will start working on the action items.
WG 2
The individual members of WG2 are currently reviewing the different papers that Roberto had collected.
WG3
GML will start next week with the follow-up from the meeting in October
Commission
SK forwarded a request from DE to Sophie. DE is interested in an official response from the Commission in relation to the questions that we raised on behalf of them during our last meeting in May. In addition, SK asked Sophie about the type of evidence needed from WG2.
AMR
SA and SK attended the EAAD event of ECDC. SA is involved in ECDC’s survey activity. ESNO reached out to PGEU, EPF and us to see if are interested in discussing further about AMR. A meeting was proposed by Ber. A data has not been set yet.
Shortages
Good feedback was provided in relation to our survey. A number of associations are inquiring about follow-up activities. In addition, Amgen is interested in funding a policy study. The Board leads are aware and we will start discussions this week.
Dissemination of the survey is ongoing. A message will be sent next week to Presidents and Delegates with a request for further distribution on national level. Country reports for the EU5 are online. Country reports for Ireland and Greece are being finalised. One for Romania is going to be drafted.
EMA
The EMA reached out to us in relation to the participation in scientific procedure (more information HERE). Initial feedback is needed by 29 November.
FMD
AS and SK will be attending the Stakeholder meeting and the extraordinary Board meeting on Tuesday. Main discussion items are alert handling, the community pharmacy portals and bulk verification. In addition, we will be launching a data gathering activity to obtain information on the status of FMD implementation in our member countries.
Changing roles of HPs
The Board leads have kicked off their activity. In early December we will be discussing the first draft of the business case.
COPHELA
Prof Atkinson finally got back to us. He outlined that the involvement of EAHP rather depends upon our interest. We could opt for minimal involvement which would mean advertising the COPHELA meetings and publications on our website. Or we could be involved in production actions and run surveys in Latin America. SEFH is involved in COPHELA.
Grants/funding opportunities
VD due to her previous work has experience in the drafting of grant proposals. She shared some interesting ideas in relation to different funding opportunities. She prepared a summary on the activities of the Open Society Foundation (see HERE).
The EMA also released draft guidelines on excipients in the label and package leaflet of medicinal products for human use (see HERE). In the past we decided not to participate in such specific consultation requests. However, given that the consultation concerns patient leaflets should we provide input?
Presidents guests
Positive replies have so far been received from all pharmacy organisations (ASHP, PGEU, ESOP, ESCP, EAFP). EIPG also expressed interested as well as EDQM, UEMS, ENDA and ECCO (not yet confirmed).
CTF meeting @ Congress
We received positive responses from 10 countries (BE, DE, FR, EL, IE, MT, NL, SK, ES and RO). AT and SI have expressed interest. We are still missing official and final confirmations, but realistically we are looking at welcoming around 10 to 12 countries. WG3 members (provided that their country is joining) will be invited. We have a meeting room at the Congress centre that is big enough to fit the entire group in u-shape.
EJHP – position paper publication
IVG met with Lindsey on Friday. The position papers need to be submitted by invitation. Lindsey will draft a schedule for SK. SK will take care of the submission. Regarding the old papers, she highlighted that they could have a negative impact since they might not be cited as widely as new articles. Given the importance of some of the topics, we should discuss the possibility of an update for some of the papers. Below please find all position papers:
Statement on Hospital Pharmacy Specialisation (2011)
Statement on Patient Safety (2011)
EAHP Statement on Medicines Shortages (2012)
EAHP Statement on the need for barcoding of the single dose administered in hospitals (2012)
EAHP Statement on clinical trials (2012)
EAHP Statement on public spending austerity and its impact upon access to medicines and patient safety (2013)
EAHP Statement on medical device regulation (2013)
EAHP Statement on sustainable and equitable access to medicines (2014)
EAHP Policy Statement on an ageing society (2016)
EAHP Position Paper on eHealth and mHealth (2017)
EAHP Position Paper on Biosimilar Medicines (2018)
EAHP Position Paper on Procurement (2018)
EAHP Position Paper on Antimicrobial Resistance (2018)
An update would be for the statements on the specialisation, patient safety and shortages.
Next policy call? In December after you are back from ASHP?
